Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002030450-24-000001
Filing Date
2024-07-17
Accepted
2024-07-17 13:45:37
Documents
1
Effectiveness Date
2024-07-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8668
  Complete submission text file 0002030450-24-000001.txt   9746
Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
Belenos Biosciences, Inc. (Filer) CIK: 0002030450 (see all company filings)

EIN.: 993088597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-519049 | Film No.: 241121715